Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR
COMPUTE
2 other identifiers
interventional
55
1 country
1
Brief Summary
The primary objective of this pilot study is to program an opioid use disorder (OUD) clinical decision support (CDS) tool for use in an electronic medical record (EMR) and obtain high primary care physician (PCP) usability and acceptability. The OUD-CDS is based on the NIDA-Blending Initiative white paper, "Clinical Decision Support for Opioid Use Disorders: Working Group Report," which itself is based on national evidence-based guidelines (American Society of Addiction Medicine (ASAM 2015), VA (VA 2015). As such, this pilot study aims to help PCPs achieve accepted standards of care in OUD treatment. The secondary objectives of this pilot study are to evaluate the usefulness of the tool by comparing OUD case-finding, medication-assisted therapy (MAT) and referral patterns pre- and post-CDS deployment for PCPs with and without CDS access.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2018
CompletedFirst Submitted
Initial submission to the registry
May 9, 2018
CompletedFirst Posted
Study publicly available on registry
June 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2019
CompletedResults Posted
Study results publicly available
March 10, 2020
CompletedMarch 17, 2020
February 1, 2019
10 months
May 9, 2018
January 29, 2020
March 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intervention PCP Confidence in Assessing and Treating OUD
\# of intervention PCPs who report feeling "moderately" or "very" confident in assessing and treating OUD.
This outcome measure was calculated at approximately month 10 of the pilot study
Intervention PCP Likeliness to Recommend Use of the OUD-CDS
\# of PCPs with CDS access who rate the OUD-CDS \>4 on a 5-point Likert scale of likeliness to recommend use of the tool to their colleagues. The scale ranges from 1-"not at all likely" to 5-"very likely," with higher values representing a higher likelihood of recommending the OUD-CDS to other colleagues.
This was calculated after PCP surveys were completed, approximately month 10
Secondary Outcomes (3)
Compare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.
This was calculated at the end of the pilot study (month 8).
Compare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.
This was calculated at the end of the pilot study (month 8).
Compare Post-intervention Referral Patterns Between Intervention and Control Groups
This was calculated at the end of the pilot study (month 8).
Study Arms (3)
Waivered Providers Receive the Opioid Wizard
EXPERIMENTALAll providers who have a buprenorphine waiver will receive the OUD clinical decision support tool (Opioid Wizard).
Does not Receive the Opioid Wizard
NO INTERVENTIONAll non-buprenorphine waivered providers will be randomized to receive or not receive the Opioid Wizard. This arm of providers will continue to treat their patients as usual.
Non-Waivered Providers who receive Opioid Wizard
EXPERIMENTALAll non-buprenorphine waivered providers will be randomized to receive or not receive the Opioid. This arm of providers will receive the OUD clinical decision support tool (Opioid Wizard).
Interventions
The Opioid Wizard is an OUD clinical decision support tool for primary care providers.
Eligibility Criteria
You may qualify if:
- Be an MD, Doctor of Osteopathy, Nurse Practitioner or Physician's Assistant engaged in independent primary care of adults at HealthPartners or Park Nicollet
- Have at least schedule 3 DEA prescribing privileges
- Voluntarily provide written informed consent to participate in this study
You may not qualify if:
- Less than half-time clinical primary care responsibilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HealthPartners Institutelead
- National Institute on Drug Abuse (NIDA)collaborator
- Hennepin Healthcare Research Institutecollaborator
Study Sites (1)
HealthPartners
Bloomington, Minnesota, 55425, United States
Related Publications (1)
Rossom RC, Sperl-Hillen JM, O'Connor PJ, Crain AL, Nightingale L, Pylkas A, Huntley KV, Bart G. A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder. Addict Sci Clin Pract. 2021 Jun 15;16(1):37. doi: 10.1186/s13722-021-00245-7.
PMID: 34130758DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Rebecca C Rossom
- Organization
- HealthPartners Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2018
First Posted
June 18, 2018
Study Start
April 30, 2018
Primary Completion
February 14, 2019
Study Completion
February 14, 2019
Last Updated
March 17, 2020
Results First Posted
March 10, 2020
Record last verified: 2019-02